相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer
Jen N. Goh et al.
BIOLOGICAL REVIEWS (2016)
Tumor-associated macrophages and anti-tumor therapies: complex links
Cristina Belgiovine et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Obesity-associated NLRC4 inflammasome activation drives breast cancer progression
Ryan Kolb et al.
NATURE COMMUNICATIONS (2016)
Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy
Carly Bess Williams et al.
NPJ BREAST CANCER (2016)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer
Satu Tiainen et al.
HISTOPATHOLOGY (2015)
Synergistic Effect of Trabectedin and Olaparib Combination Regimen in Breast Cancer Cell Lines
Sonia Avila-Arroyo et al.
JOURNAL OF BREAST CANCER (2015)
Essential Role of Lysophosphatidylcholine Acyltransferase 3 in the Induction of Macrophage Polarization in PMA-Treated U937 Cells
Kosuke Taniguchi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
The Role of Cytokines in Breast Cancer Development and Progression
Marcela Esquivel-Velazquez et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 6 (STAT6) with Cell-Permeable, Phosphatase-Stable Phosphopeptide Mimics Potently Inhibits Tyr641 Phosphorylation and Transcriptional Activity
Pijus K. Mandal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Therapeutic potential of chemokine signal inhibition for metastatic breast cancer
Takanori Kitamura et al.
PHARMACOLOGICAL RESEARCH (2015)
Targeting breast cancer through its microenvironment: Current status of preclinical and clinical research in finding relevant targets
H. H. Nienhuis et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Macrophages and cancer: from mechanisms to therapeutic implications
Renato Ostuni et al.
TRENDS IN IMMUNOLOGY (2015)
Stat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells
Hsueh-Te Lee et al.
ONCOTARGET (2015)
Morphine Modulates Interleukin-4-or Breast Cancer Cell-induced Pro-metastatic Activation of Macrophages
Samira Khabbazi et al.
SCIENTIFIC REPORTS (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
Induced PD-L1 Expression Mediates Acquired Resistance to Agonistic Anti-CD40 Treatment
Alfred Zippelius et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Hyaluronan, inflammation, and breast cancer progression
Kathryn L. Schwertfeger et al.
FRONTIERS IN IMMUNOLOGY (2015)
Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs
Xuemei Jia et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
Yifang Wei et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
M. D'Incalci et al.
BRITISH JOURNAL OF CANCER (2014)
Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
Brian Ruffell et al.
CANCER CELL (2014)
B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas
Nesrine I. Affara et al.
CANCER CELL (2014)
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
Yu Zhu et al.
CANCER RESEARCH (2014)
A decade of progress in adipose tissue macrophage biology
Andrea A. Hill et al.
IMMUNOLOGICAL REVIEWS (2014)
Macrophage Polarization in Inflammatory Diseases
Yan-Cun Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Dimethyl Sulfoxide Suppresses Mouse 4T1 Breast Cancer Growth by Modulating Tumor-Associated Macrophage Differentiation
Rui Deng et al.
JOURNAL OF BREAST CANCER (2014)
CCL2 Shapes Macrophage Polarization by GM-CSF and M-CSF: Identification of CCL2/CCR2-Dependent Gene Expression Profile
Elena Sierra-Filardi et al.
JOURNAL OF IMMUNOLOGY (2014)
Harnessing the immune system for the treatment of breast cancer
Xinguo Jiang
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2014)
STAT signaling in different breast cancer sub-types
Priscilla A. Furth
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
TSC1 controls macrophage polarization to prevent inflammatory disease
Linnan Zhu et al.
NATURE COMMUNICATIONS (2014)
Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer
Parvin Forghani et al.
CANCER MEDICINE (2014)
The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets
M. Isabel Palacios-Arreola et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Theerawut Chanmee et al.
CANCERS (2014)
Green tea compounds in breast cancer prevention and treatment
Min-Jing Li et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
CTLA-4Ig immunotherapy of obesity-induced insulin resistance by manipulation of macrophage polarization in adipose tissues
Masakazu Fujii et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization
Ji-Young Jang et al.
BMC CANCER (2013)
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano et al.
CANCER CELL (2013)
Macrophage Regulation of Tumor Responses to Anticancer Therapies
Michele De Palma et al.
CANCER CELL (2013)
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Shahneen K. Sandhu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer
Xiaoqiang Tang
CANCER LETTERS (2013)
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
Jonathan B. Mitchem et al.
CANCER RESEARCH (2013)
CCL5 as a potential immunotherapeutic target in triple-negative breast cancer
Dandan Lv et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Tumor microenvironment profoundly modifies functional status of macrophages: Peritoneal and tumor-associated macrophages are two very different subpopulations
Dayron Rodriguez et al.
CELLULAR IMMUNOLOGY (2013)
Molecular Pathways: Adipose Inflammation as a Mediator of Obesity-Associated Cancer
Louise R. Howe et al.
CLINICAL CANCER RESEARCH (2013)
Tumour-associated macrophages and cancer
Jenny Cook et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Role of adipokines and cytokines in obesity-associated breast cancer: Therapeutic targets
Sajid Khan et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Tumor associated macrophages and neutrophils in cancer
Maria Rosaria Galdiero et al.
IMMUNOBIOLOGY (2013)
Anti-tumour strategies aiming to target tumour-associated macrophages
Xiaoqiang Tang et al.
IMMUNOLOGY (2013)
Targeting tumor-infiltrating macrophages to combat cancer
Roheena Z. Panni et al.
IMMUNOTHERAPY (2013)
Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity
Leah A. Mitchell et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
The role of tumor-associated macrophages in breast cancer progression
Elias Obeid et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Chemokines in tumor progression and metastasis
Purvaba J. Sarvaiya et al.
ONCOTARGET (2013)
Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
John Stagg et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2013)
The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction
Carsten Goessl et al.
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN 2011 (2012)
Macrophage polarization: An opportunity for improved outcomes in and regenerative medicine
Bryan N. Brown et al.
BIOMATERIALS (2012)
Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology
Oscar M. Pello et al.
BLOOD (2012)
Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression
Xuezheng Sun et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling
Lucy Liu et al.
CANCER BIOLOGY & THERAPY (2012)
Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
Elizabeth S. Nakasone et al.
CANCER CELL (2012)
S100A7 Enhances Mammary Tumorigenesis through Upregulation of Inflammatory Pathways
Mohd W. Nasser et al.
CANCER RESEARCH (2012)
Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
Melody A. Swartz et al.
CANCER RESEARCH (2012)
CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells
Akihiro Tsuyada et al.
CANCER RESEARCH (2012)
Macrophages in Tumor Microenvironments and the Progression of Tumors
Ning-Bo Hao et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models
Massimo Zollo et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade
Leisha A. Emens
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Curcumin molecular targets in obesity and obesity-related cancers
Adeeb Shehzad et al.
FUTURE ONCOLOGY (2012)
Macrophage Migration Inhibitory Factor (MIF): A Key Player in Protozoan Infections
Juan de Dios Rosado et al.
International Journal of Biological Sciences (2012)
Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPARγ independent manner
Zhang-Feng Zhong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Macrophage plasticity and polarization: in vivo veritas
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Wnt5a Induces a Tolerogenic Phenotype of Macrophages in Sepsis and Breast Cancer Patients
Caroline Bergenfelz et al.
JOURNAL OF IMMUNOLOGY (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes
Tim D. Eubank et al.
BLOOD (2011)
Design and development of a peptide-based adiponectin receptor agonist for cancer treatment
Laszlo Otvos et al.
BMC BIOTECHNOLOGY (2011)
Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome
Michael J. Campbell et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study
Ying Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
Markus Chmielewski et al.
CANCER RESEARCH (2011)
Tumor-Associated Macrophages Mediate Immunosuppression in the Renal Cancer Microenvironment by Activating the 15-Lipoxygenase-2 Pathway
Irina Daurkin et al.
CANCER RESEARCH (2011)
Cancer-promoting tumor-associated macrophages: New vistas and open questions
Alberto Mantovani et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Signal transducer and activator of transcription 3 inhibitors: a patent review
Brent D. G. Page et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Tanaya Shree et al.
GENES & DEVELOPMENT (2011)
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors
Lauren L. C. Marotta et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Macrophage regulation of tumor angiogenesis: Implications for cancer therapy
Mario Leonardo Squadrito et al.
MOLECULAR ASPECTS OF MEDICINE (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Obesity, Inflammation, and Postmenopausal Breast Cancer: Therapeutic Implications
Antonio Maccio et al.
THESCIENTIFICWORLDJOURNAL (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Toby Lawrence et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy
Saul J. Priceman et al.
BLOOD (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Clinical overview of sorafenib in breast cancer
Alvaro Moreno-Aspitia
FUTURE ONCOLOGY (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
The multikinase inhibitor Sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE2 in murine macrophages
Justin P. Edwards et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Osteoblasts Are a Major Source of inflammatory Cytokines in the Tumor Microenvironment of Bone Metastatic Breast Cancer
Karen M. Bussard et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
NF-κB as a central regulator of macrophage function in tumors
Subhra K. Biswas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
An Antimicrobial Peptide Regulates Tumor-Associated Macrophage Trafficking via the Chemokine Receptor CCR2, a Model for Tumorigenesis
Ge Jin et al.
PLOS ONE (2010)
Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors
Jianyong Chen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Louis M. Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells
Andrew J. Rech et al.
CANCER VACCINES (2009)
Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia
Hsin-Yu Fang et al.
BLOOD (2009)
Granulocyte Macrophage Colony-Stimulating Factor Inhibits Breast Cancer Growth and Metastasis by Invoking an Anti-Angiogenic Program in Tumor-Educated Macrophages
Tim D. Eubank et al.
CANCER RESEARCH (2009)
Angiopoietin-like Protein 2 Promotes Chronic Adipose Tissue Inflammation and Obesity-Related Systemic Insulin Resistance
Mitsuhisa Tabata et al.
CELL METABOLISM (2009)
Cellular and molecular pathways linking inflammation and cancer
Chiara Porta et al.
IMMUNOBIOLOGY (2009)
Cisplatin primes murine peritoneal macrophages for enhanced expression of nitric oxide, proinflammatory cytokines, TLRs, transcription factors and activation of MAP kinases upon co-incubation with L929 cells
Puja Chauhan et al.
IMMUNOBIOLOGY (2009)
Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression
Hiroshi Fujimoto et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Development of HIF-1 inhibitors for cancer therapy
Barbara Onnis et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis
Yoshiaki Kubota et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
Dong-Ming Kuang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Tumor-Associated Macrophage-Induced Invasion and Angiogenesis of Human Basal Cell Carcinoma Cells by Cyclooxygenase-2 Induction
Jeng-Wei Tjiu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
G. Solinas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia
Carl L. Manthey et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Dasatinib is a potent inhibitor of tumour-associated macrophages, osteoclasts and the FMS receptor
N. Brownlow et al.
LEUKEMIA (2009)
The inflammatory chemokines CCL2 and CCL5 in breast cancer
Gali Soria et al.
CANCER LETTERS (2008)
The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages
Paola Allavena et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma
Xiao-Dong Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells
Satoko Matsumura et al.
JOURNAL OF IMMUNOLOGY (2008)
Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells
Baldev Vasir et al.
JOURNAL OF IMMUNOLOGY (2008)
A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis
Susanna Lewen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Tumor microenvironment: The role of the tumor stroma in cancer
Hanchen Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Immune cells as anti-cancer therapeutic targets and tools
Magnus Johansson et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
Jun-Li Luo et al.
NATURE (2007)
Regulation of Metastases by signal transducer and activator of transcription 3 signaling pathway: Clinical implications
Suyun Huang
CLINICAL CANCER RESEARCH (2007)
IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo
Stephanie K. Watkins et al.
JOURNAL OF IMMUNOLOGY (2007)
P50 nuclear factor-κB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance
Alessandra Saccani et al.
CANCER RESEARCH (2006)
The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients
Neora Yaal-Hahoshen et al.
CLINICAL CANCER RESEARCH (2006)
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Yunping Luo et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer
L. Zelek et al.
BRITISH JOURNAL OF CANCER (2006)
Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts
P Paulus et al.
CANCER RESEARCH (2006)
Elevated serum levels of vascular endothelial growth factor are associated with tumor-associated macrophages in primary breast cancer
L Vicioso et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Molecular links between obesity and breast cancer
A. M. Lorincz et al.
ENDOCRINE-RELATED CANCER (2006)
Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity
BJ Moeller et al.
CANCER CELL (2005)
CD40 ligation activates murine macrophages via an IFN-γ-dependent mechanism resulting in tumor cell destruction in vitro
IN Buhtoiarov et al.
JOURNAL OF IMMUNOLOGY (2005)
IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation
T Lawrence et al.
NATURE (2005)
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells
S Nam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Δ-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response
RJ McKallip et al.
JOURNAL OF IMMUNOLOGY (2005)
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer
KD Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
被撤回的出版物: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007)
A Fukuhara et al.
SCIENCE (2005)
Macrophage responses to hypoxia - Implications for tumor progression and anti-cancer therapies
C Lewis et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
STAT3 activation in macrophages following infection with Salmonella
T Lin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern
KJ Smith et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2004)
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses
PC Rodriguez et al.
CANCER RESEARCH (2004)
Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice
S Aharinejad et al.
CANCER RESEARCH (2004)
A dual role for tumor-derived chemokine RANTES (CCL5)
EP Adler et al.
IMMUNOLOGY LETTERS (2003)
Regulation of the chemokine receptor CXCR4 by hypoxia
T Schioppa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A critical role for stat3 signaling in immune tolerance
FD Cheng et al.
IMMUNITY (2003)
HIF-1α is essential for myeloid cell-mediated inflammation
T Cramer et al.
CELL (2003)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2002)
Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation
C Berlato et al.
JOURNAL OF IMMUNOLOGY (2002)
Tumor-associated macrophages in breast cancer
RD Leek et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2002)
Expression of HIF-Iα by human macrophages:: implications for the use of macrophages in hypoxia-regulated cancer gene therapy
B Burke et al.
JOURNAL OF PATHOLOGY (2002)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation in tumor-associated macrophages
A Sica et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
